What is Doctor's Data?
Doctor's Data, Inc. (DDI) operates as a premier clinical laboratory, specializing in the assessment of essential and toxic elemental profiles across various human tissues. With a long-standing reputation for pioneering functional testing, the company provides a comprehensive suite of diagnostic services. These include, but are not limited to, the detection of heavy metal burdens, nutritional status evaluations, gastrointestinal health assessments, and the analysis of metabolic abnormalities. By focusing on the intersection of environmental origin and physiological health, DDI serves as a vital partner for clinicians aiming to prevent and treat complex, chronic conditions through evidence-based laboratory insights.
How much funding has Doctor's Data raised?
Doctor's Data has raised a total of $2.8M across 2 funding rounds:
Debt
$1M
Debt
$1.8M
Debt (2020): $1M with participation from PPP
Debt (2021): $1.8M led by PPP
Key Investors in Doctor's Data
PPP
Public-Private Partnership
What's next for Doctor's Data?
With the recent influx of capital, Doctor's Data is well-positioned to accelerate its enterprise-level growth strategy. The firm is expected to prioritize the expansion of its diagnostic capabilities, potentially integrating advanced analytical technologies to enhance the speed and accuracy of its specialty testing services. As the demand for functional medicine and personalized health assessments continues to rise, DDI's strategic roadmap likely includes scaling its global laboratory operations and deepening its research into environmental health markers. This phase of development will be critical in maintaining the company's competitive edge in the diagnostic testing market, ensuring that it remains at the forefront of clinical innovation and patient outcome optimization.
See full Doctor's Data company page
